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AIMS AND SCOPE 
 
 
 
Aims and Scope 
npj Aging & Mechanisms of Disease is an online Open 
Access multidisciplinary journal which provides a forum for 
the world’s most important research in the field of aging and 
disease.  
 
The journal considers Reviews and Articles from all relevant 
disciplines: mechanistic understanding of, and intervention 
to, the aging process in humans, age-associated diseases, 
epidemiology of age-associated pathophysiology, and 
longevity. The journal also has an emphasis on emerging 
age-related medicine - stem cells, circadian rhythms and 
metabolism – with clinical and translational insights into 
applications to humans.  
 
From the medical, clinical and translational perspectives, 
the journal considers biochemistry, physiology, immunology, 
endocrinology, genetics and genomics, with subspecialties 
in aging diseases such as, but not limited to, neurology, 
psychology, oncology, cardiology, nephrology, 
orthopaedics, dermatology, urology and ophthalmology. 
 
Relationship to other Nature journals 
npj Aging and Mechanisms of Disease is a new open 
access, online-only, journal published in partnership 
between Springer Nature and the Japanese Society of Anti-
Aging Medicine. 
 
npj Aging and Mechanisms of Disease is editorially 
independent. The editors make their own decisions, 
independently of the other Springer Nature journals.  
 
If a paper is rejected from one Springer Nature journal, the 
authors can use an automated manuscript transfer service 
to submit the paper to npj Aging and Mechanisms of 
Disease via a link sent to them by the editor handling the 
manuscript.  
 
 
In cases where manuscripts are rejected from npj Aging and 
Mechanisms of Disease, authors may wish to use the same 
manuscript transfer service to submit their paper to other 
Springer Nature journals. 
 
For more information, please consult the following: 
Details of the manuscript transfer service 
Listing of all Nature journals 
 
 
Journal Details 
 
Editor in Chief:  
Kazuo Tsubota 
Keio University School of Medicine 
 
Associate Editors: 
Johan Auwerx (Ecole Polytechnique Fédérale, Switzerland) 
Shin-ichiro Imai (Washington University, USA) 
Mark Mattson (National Institute of Aging, USA) 
Tohru Minamino (Niigata University, Japan) 
Satchin Panda (Salk Institute, USA) 
Andrew Steptoe (University College London UK) 
Tetsuya Yamasoba (University of Tokyo, Japan) 
 
Editorial office:  
npj Aging and Mechanisms of Disease  
Editorial Office 
Springer Nature 
Chiyoda Building 
2-37 Ichigayatamachi, Shinjuku-ku  
Tokyo 162-0843 Japan 
Email: npjamd@nature.com 
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ARTICLE TYPE SPECIFICATIONS 
 
Article Description Abstract  Word Limit Tables/ 
Figures 
References 
Article  
A complete, comprehensive report of original 
research. An Article usually has a fairly complex 
narrative that is based on multiple techniques 
and/or approaches. 
Unstructured abstract 
Max word limit: 250 
 
5,000 words max 
excluding 
abstract, 
references, 
figures and 
tables.  
Max of 6  
Max of 50. 
Please use 
as current 
as possible.  
Review  
A comprehensive synthesis and/or analysis of 
specific topics. A short Introduction giving the 
rationale for the review should be followed by 
sections with appropriate subheadings, followed 
by a conclusions section at the end. The 
standard footer headings (Acknowledgements, 
Contributions, Competing Interests, Funding) 
are required. All invited reviews will undergo 
peer review prior to acceptance 
Unstructured abstract 
Max word limit: 250 
 
 
5,000 words max 
excluding 
abstract, 
references, 
figures and 
tables.  
Max of 8 Max of 100 
Editorials 
An authoritative timely opinion on an issue or a 
paper; it is usually written or invited by the 
Editor-in-Chief 
None 1,000 words Max of 2 Max of 15 
Brief Communication 
A concise report of research of high quality and 
broad interest to a journal’s target audience. 
Usually a short report of interim work or final 
report of research that does not warrant a full 
research paper publication. 
Unstructured abstract 
Max word limit: 150 
 
800 words Max of 2 Max of 10 
Perspective 
It should provide an evidence-based opinion on 
a particular article or subject. There should be a 
short introduction, followed by relevant section 
headings and a conclusions’ section at the end. 
The standard footer headings 
(Acknowledgements, Contributions, Competing 
Interests, Funding) are required. 
Unstructured abstract 
Max word limit: 250 2,000 words Max of 3 Max of 50 
 
Word Limit 
Word limits are provided for guidance only. The Editors will consider submissions that exceed the recommended limit, subject to 
feedback received during peer review. 
 
PREPARATION OF ARTICLES 
 
 
Please note that Articles must contain the following 
components. Please see below for further details. 
 
• Title page 
• Abstract and keywords 
• Introduction 
• Results 
• Discussion  
• Methods 
• Acknowledgements 
• Competing Interests 
• Contributions 
• Funding 
• References 
• Figure legends 
• Tables 
• Figures 
 
Cover Letter: The uploaded cover letter must state the 
material is original, has not been previously published and 
has not been submitted for publication elsewhere while 
under consideration. A Competing Interests statement 
should also be included. 
 
Manuscript text: All textual content is provided in a single 
file, prepared using either Word or TeX/LaTeX; figures are 
provided in individual files.  
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Word: Nature Partner Journals do not use a manuscript 
template for Word documents. The manuscript file should 
be formatted as double spaced, single-column text without 
justification. Pages should be numbered using an Arabic 
numeral in the footer of each page. Standard fonts are 
recommended and the 'symbols' font should be used for 
representing Greek characters.  
 
TeX/LaTeX: Authors submitting LaTeX files may use any of 
the standard class files such as article.cls, revtex.cls or 
amsart.cls. Non-standard fonts should be avoided; please 
use the default Computer Modern fonts. For the inclusion of 
graphics, we recommend graphicx.sty. Please use 
numerical references only for citations. There is no need to 
spend time visually formatting the manuscript: journal style 
will be imposed when the paper is prepared for publication. 
References should be included within the manuscript file 
itself.  
 
BibTeX Bibliography Files: Authors who wish to use 
BibTeX to prepare their references should therefore copy 
the reference list from the .bbl file that BibTeX generates 
and paste it into the main manuscript .tex file (and delete 
the associated \bibliography and \bibliographystyle 
commands). As a final precaution, authors should ensure 
that the complete .tex file compiles successfully on their 
own system with no errors or warnings, before submission. 
 
Title Page: The title page should bear the title of the paper, 
the full names of all the authors and their affiliations, 
together with the name, full postal address, telephone and 
e-mail address of the author to whom all correspondence is 
to be addressed.  
• The title should be brief, informative, of 150 characters 
or less.  
• The running title should consist of no more than 50 
letters and spaces. It should be as brief as possible, 
convey the essential message of the paper and 
contain no abbreviations.  
• Authors should disclose the sources of any support for 
the work, received in the form of grants and/or 
equipment and drugs. 
• If authors regard it as essential to indicate that two or 
more co-authors are equal in contribution status, they 
may be identified by an asterisk symbol with the 
caption ‘These authors contributed equally to this 
work’ immediately under the address list. 
 
Abstract: Abstracts should be unstructured and of no more 
than 250 word 
 
Introduction: The Introduction should assume that the 
reader is knowledgeable in the field and should therefore be 
as brief as possible, but can include a short background 
description/overview where desirable. 
 
Results: The Results section should briefly present the 
experimental data in text, tables or figures. Tables and 
figures should not be described extensively in the text. 
Section sub-headings can be used to aid clarity. 
 
Discussion: The discussion should focus on the 
interpretation and the significance of the findings with 
concise objective comments that describe their relationship 
to other work in the area. It should not repeat information in 
the results section.  
Methods: This section should contain sufficient detail, so 
that all experimental procedures can be reproduced, and 
include references. However, methods that have been 
published in detail elsewhere should not be described in 
detail. Authors should provide the name and location of the 
manufacturer for any specifically named equipment and 
instruments; if applicable, all drugs should be identified by 
their pharmaceutical names, and by their trade name if 
relevant. Section sub-headings should be used to aid clarity. 
 
Availability of Data and Materials: An inherent principle of 
publication is that others should be able to replicate and 
build upon the authors' published claims. A condition of 
publication is that authors are required to make materials, 
data, code, and associated protocols promptly available to 
readers without undue qualifications.  
 
Submission of a manuscript to npj Aging and Mechanisms of 
Disease implies that materials described in the manuscript, 
including all relevant raw data, will be freely available to any 
scientist wishing to use them for non-commercial purposes, 
without breaching participant confidentiality.  
 
npj Aging and Mechanisms of Disease strongly encourages 
that all datasets on which the conclusions of the paper rely 
should be available to readers. We encourage authors to 
ensure that their datasets are either deposited in publicly 
available repositories (where available and appropriate) or 
presented in the main manuscript or additional supporting 
files whenever possible. Please see Springer Nature’s 
information on recommended repositories. General 
repositories - for all types of research data - such as 
figshare and Dryad may be used where appropriate.  
 
Where a widely established research community 
expectation for data archiving in public repositories exists, 
submission to a community-endorsed, public repository is 
mandatory. Persistent identifiers (such as DOIs and 
accession numbers) for relevant datasets must be provided 
in the paper. 
 
Acknowledgements: These should be brief and should 
include sources of support including sponsorship (e.g., 
university, charity, commercial organisation) and sources of 
material (e.g., novel drugs) not available commercially. 
 
Contributions: The exact role(s) of each author should be 
included in the declaration. For research manuscripts, one 
or more of the authors should be identified as the guarantor. 
Only those who have made substantial contributions to the 
study and/or preparation of the manuscript should be 
acknowledged as authors and named in full.  
 
Competing Interests: Authors must declare whether or not 
there are any competing interests in relation to the work 
described. This information must be included at this stage 
and will be published as part of the paper. Conflict of interest 
should be noted in the cover letter and in the paper. Please 
see the Conflict of Interest documentation in the Editorial 
Policy section for detailed information. 
 
Funding: Authors should declare the source of funding for 
their research, if applicable. 
 
References: All necessary references should be included in 
order to credit previous work directly relevant to the article. 
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This should translate to a number of references within the 
range described in the article type specification section. 
References should follow the Vancouver format. In the text 
they should appear as superscript numbers starting at 1 and 
at the end of the paper they should be listed (double-
spaced) in numerical order corresponding to the order of 
citation in the text. Where a reference is to appear next to a 
number in the text, for example, following an equation, 
chemical formula or biological acronym, citations should be 
written as (ref. X) and not as superscript. Example: 
“detectable levels of endogenous Bcl-2 (ref. 3), as 
confirmed by western blot.” 
 
All authors should be listed for papers with up to five 
authors; for papers with more than five authors, the first only 
should be listed, followed by et al. Abbreviations for titles of 
medical periodicals should conform to those used in the 
latest edition of Index Medicus. The first and last page 
numbers for each reference should be provided. Abstracts 
and letters must be identified as such. Papers in the press 
may be included in the list of references. 
 
Personal communications must be allocated a number and 
included in the list of references in the usual way or simply 
referred to in the text; the authors may choose which 
method to use. In either case authors must obtain 
permission from the individual concerned to quote his/her 
unpublished work. 
 
Sample References 
Journal article, up to five authors: 
Belkaid Y, & Rouse BT. Natural regulatory T cells in 
infectious disease. Nat Immunol 6: 353–360 (2005) 
 
Journal article, more than five authors  
Miller W et al. Cytomegalovirus infection after bone marrow 
transplantation: an association with acute graft-v-host 
disease. Blood 67: 1162–1167 (1986) 
 
Online journals (treat e-numbers like print page numbers;  
(OK to have a DOI in lieu of volume and page numbers) 
Hill, W. G., Goddard, M. E. & Visscher, P. M. Data and 
theory point to mainly additive genetic variance for complex 
traits. PLoS Genet. 4, e1000008 (2008).  
 
Journal article, e-pub ahead of print 
Bonin M et al. F-ara-A pharmacokinetics during reduced-
intensity conditioning therapy with fludarabine and busulfan. 
Bone Marrow Transplant 2007; e-pub ahead of print 8 
January 2007; doi:10.1038/sj.bmt.1705565 
 
Journal article, in the press: 
Gallardo RL, Juneja HS, & Gardner FH. Normal human 
marrow stromal cells induce clonal growth of human 
malignant T-lymphoblasts. Int J Cell Cloning (in the press). 
 
Letter 
Caocci G, Pisu S. Overcoming scientific barriers and human 
prudence [letter]. Bone Marrow Transplant. 38, 829–830 
(1999). 
 
Publicly available preprint 
Babichev, S. A., Ries, J. & Lvovsky, A. I. Quantum scissors: 
teleportation of single-mode optical states by means of a 
nonlocal single photon. Preprint at http://arXiv.org/quant-
ph/0208066 (2002). 
Book (publisher’s location is optional. If used, include state 
in two-letter abbreviation or country for all cities except New 
York and London) 
Diener, B. J. & Wilkinson, P. (eds) Transplantation 
Techniques (Harvard Univ. Press, 1989). 
 
Meyer, H. A. The Role of Abdominal Fat 2nd edn, Vol. 2 
(CRC Press, Boca Raton, FL, 1970). 
 
Chapter in book (if more than two editors, use first editor’s 
name followed by et al.) 
Harley, N. H. & Vivian, L. in Mechanisms of Disease 4th 
edn, Vol. 2 (eds Sodeman, W. A. & Smith, A.) Ch. 3 
(Springer, Dordrecht, The Netherlands, 1974). 
 
Published abstract (page number is optional) 
Feig, S. A. et al. Bone marrow transplantation for 
neuroblastoma. Exp. Hematol. 13, 123, abstr. 102 (1985). 
 
 
Online references (add last-accessed date if available) 
Manaster, J. Sloth squeak. Scientific American Blog Network. 
http://blogs.scientificamerican.com/psi-vid/2014/04/09/sloth-
squeak (2014). 
 
National Institutes of Health. Genome-wide association 
studies (GWAS).  
http://grants.nih.gov/grants/gwas/index.htm. Accessed 4 
January 2007. 
 
Meeting 
Brentjens, R. et al. Marked regression of adenopathy 
following infusion of autologous T cells. 13th annual meeting 
of the American Society of Gene and Cell Therapy, 
Washington, DC, 17–22 May 2010. 
 
Figure Legends: These should be brief, specific and 
appear on a separate manuscript page after the References 
section.  
 
Tables: These should be labelled sequentially and cited 
within the text. Each table should be presented on its own 
page, numbered and titled. Reference to table footnotes 
should be made by means of Arabic numerals. Tables 
should not duplicate the content of the text. They should 
consist of at least two columns; columns should always 
have headings. Authors should ensure that the data in the 
tables are consistent with those cited in the relevant places 
in the text, totals add up correctly, and percentages have 
been calculated correctly. Tables should only be used to 
present essential data. Each must be on a separate sheet 
with a title or caption and be clearly labelled, sequentially. 
Please make sure each table is cited within the text and in 
the correct order, e.g. (Table 3). Tables should ideally be 
presented in Excel, one table per workbook. It is imperative 
that the tables are editable. Please save the files with 
extensions .xls / .xlsx / .ods / or .doc or .docx. Please ensure 
that you provide a 'flat' file, with single values in each cell 
with no macros or links to other workbooks or worksheets 
and no calculations or functions. 
 
Figures: Figures and images should be labelled 
sequentially and cited in the text. Figures should not be 
embedded within the text but rather uploaded as separate 
files. Detailed guidelines for submitting artwork can be found 
by downloading our Artwork Guidelines. The use of three-
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dimensional histograms is strongly discouraged when the 
addition of the third dimension gives no extra information.  
 
Supplementary Information: Supplementary information 
(SI) is peer-reviewed material directly relevant to the 
conclusion of an article that is not included within the main 
body of the article. The article must be complete and self-
explanatory without the SI, which is posted on the journal's 
website and linked to the article. SI may consist of data files, 
graphics, movies or extensive tables. Please see our 
Artwork Guidelines for information on accepted file types.  
 
Authors should submit SI files in the FINAL format as they 
are not edited, typeset or changed, and will appear online 
exactly as submitted. When submitting SI, authors are 
required to: 
• Include a text summary (no more than 50 words) to 
describe the contents of each file. 
• Identify the types of files (file formats) submitted. 
• Include the text “Supplementary information is 
available at (journal name)’s website” at the end of the 
article and before the references. 
 
Reporting Tools: Please also ensure that, where relevant, 
the appropriate reporting guidance checklist (e.g. 
CONSORT for randomised controlled trials, PRISMA for 
systematic reviews, and STROBE for cohort, case-control 
and cross-sectional studies) has been completed and 
submitted as a supplementary file. These can be obtained 
from http://www.equator-network.org 
 
In order to improve the overall transparency of reporting and 
the reproducibility of published results we require that you 
complete and submit the following reporting checklist  
http://www.nature.com/authors/policies/checklist_AJ.pdf. 
 
House Style 
• All pages and lines are to be numbered.  To add page 
numbers in MS Word, go to Insert then Page 
Numbers. To add line numbers go to File, Page Setup, 
then click the Layout tab. In the Apply to box, select 
Whole document, click Line Numbers then select the 
Add line numbering check box, followed by 
Continuous.  
• Use a coarse hatching pattern rather than shading for 
tints in graphs. 
• Colour should be distinct when being used as an 
identifying tool. 
• At first mention of a manufacturer, the town (and state 
if USA) and country should be provided.  
• Units: Use metric units (SI units) as fully as possible. 
Preferably give measurements of energy in kiloJoules 
or MegaJoules with kilocalories in parentheses (1 kcal 
= 4.186kJ). Use % throughout.  
• Abbreviations: On first using an abbreviation place it in 
parentheses after the full item. Very common 
abbreviations such as FFA, RNA, need not be defined. 
Note these abbreviations: gram g; litre l;  
• Milligram mg; kilogram kg; kilojoule kJ; megajoule MJ; 
weight wt; seconds s; minutes min; hours h. Do not 
add s for plural units. 
 
Language Editing: We strongly encourage non-native 
speakers of English to take at least one of the following 
steps: 
 
• Have your manuscript reviewed for clarity by a 
colleague whose native language is English. 
• Review the tips for technical writing here: 
http://www.nature.com/authors/author_resources/how_
write.html. 
• Use an English language editing service such as 
Nature Publishing Group Language Editing. An editor 
will improve the English to ensure that your meaning is 
clear and to identify problems that require your review.  
 
Please note that the use of a language editing service is at 
the author's own expense and does not guarantee that the 
article will be selected for peer review or accepted.  
 
 
HOW TO SUBMIT 
 
 
Pre-submission Enquiries  
Please submit via our online manuscript submission system. 
 
Online Submission 
We only accept manuscript submission via our online 
manuscript submission system. Before submitting a 
manuscript, authors are encouraged to consult both our 
Editorial Policies and the submission instructions for our 
online manuscript submission system. If you have not 
already done so, please register for an account with our 
online manuscript system. You will be able to monitor the 
status of your manuscript online throughout the editorial 
process.  
 
 
Submission of Revisions 
Authors submitting a revised manuscript after review are 
asked to include the following: 
 
(1) A rebuttal letter, indicating point-by-point how you have 
addressed the comments raised by the reviewers. If you 
disagree with any of the points raised, please provide 
adequate justification in your letter.   
(2) A marked-up version of the manuscript that highlights 
changes made in response to the reviewers' comments 
in order to aid the Editors and reviewers. Do not use 
track changes or comments.  
(3) A 'clean' (non-highlighted) version of the revised 
manuscript. 
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POST-ACCEPTANCE 
 
 
Once a manuscript is accepted, the corresponding author 
must complete and sign a Creative Commons licence and 
Article Processing Charge Payment form on behalf of all 
authors and return it to the editorial office. Failure to 
promptly return the form will result in delay of publication.  
 
Publication 
Publishing Open Access will mean the paper is freely 
accessible online immediately upon publication. By paying 
this charge authors are permitted to post the final, 
published PDF of their article on a website, institutional 
repository or other free public server, immediately on 
publication.   
 
Open access articles are published under a CC BY licence 
(Creative Commons Attribution 4.0 International Licence).  
The CC BY licence is preferred by many research funding 
bodies.  It allows for maximum dissemination and re-use of 
open access materials: users are free to share (copy, 
distribute and transmit) and remix (adapt) the contribution 
including for commercial purposes, providing they attribute 
the contribution in the manner specified by the author or 
licensor (read the full legal code). 
The CC BY-NC-ND and CC BY-NC-SA licences are 
available on request: please contact the editorial office on 
acceptance of your article to discuss these options. 
 
Under Creative Commons licences, authors retain 
copyright in their work. Authors should note that some 
funders require papers to be published under a specific 
licence and so should check the funder mandate to ensure 
compliance. 
 
With regards to payment, usual credit terms are 30 days 
from receipt of invoice. Failure to pay your invoice within 
the stated credit term may result in such penalties as 
restrictions on your ability to publish with Springer Nature 
in the future, involvement of a third party debt collection 
agency and legal proceedings. For further information on 
Open Access payment please see the FAQs page.  
Open Access Waiver 
Please note that some institutions have enacted Open 
Access policies that conflict with our own. If any 
corresponding or contributing authors are from these 
institutions, you will need to provide a waiver from the 
institution of every affected author, which can be obtained 
from the institution. This waiver should be submitted at the 
same time as the Open Access Licence to Publish form.  
 
Proofs 
The corresponding author will receive an e-mail containing 
a URL linking to the proofing site. Proof corrections must 
be returned within 48 hours of receipt. Failure to do so may 
result in delayed publication. Extensive corrections cannot 
be made at this stage.  
 
Final Publication  
The final version of the manuscript is published online and 
represents the official version of the manuscript. 
 
Self-Archiving 
Authors are encouraged to submit the final version of the 
accepted, peer-reviewed manuscript to their funding body's 
archive for public release immediately upon publication and 
to deposit the final version on their institution’s repository. 
Authors should cite the publication reference and DOI 
number on any deposited version, and provide a link from it 
to the published article on the Springer Nature website. 
 
This policy complements the policies of the US National 
Institutes of Health, the Wellcome Trust and other research 
funding bodies around the world. Springer Nature 
recognises the efforts of funding bodies to increase access 
of the research they fund, and strongly encourages authors 
to participate in such efforts. 
 
 
 
PUBLICATION CHARGES 
 
Article Processing Charge 
Authors whose papers are accepted for publication in npj 
Aging and Mechanisms of Disease are required to pay an 
Article Processing Charge (APC). 
The following charges will apply for all un-solicited articles 
published in npj Aging and Mechanisms of Disease (plus 
VAT where applicable):
 
 
US UK & RoW Europe Japan China 
Original Articl $4,000 £2,650 €3,300 ¥424,000 RMB 27,900 
Other article types $1,500 £1,000 €1,250 ¥160,000 RMB 10,500 
 
Upon acceptance of their manuscript it is mandatory for 
authors of articles and reports to complete the Article 
Processing Charge payment form and licence to publish 
form and return to Springer Nature's production department 
(fax number and email included on form); processing of an 
accepted manuscript can only proceed once these forms 
have been signed and returned. 
 
Please note in regards to payment that usual credit terms 
are 30 days from receipt of invoice. Failure to pay your 
invoice within the stated credit term may result in such 
penalties as restrictions on your ability to publish with 
Springer Nature or in the Journal in the future, involvement 
of a third party debt collection agency and legal 
proceedings. 
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Article Processing Charge Waiver policy 
npj Aging and Mechanisms of Disease offers APC waivers 
to authors from HINARI countries. Discretionary APC 
waivers will be considered on a case-by-case basis, and 
may be granted in cases of financial need. All applications 
for APC waivers should be made prior to, or at the point of, 
manuscript submission. To request a waiver please contact 
us at apcwaivers@springernature.com. 
 
All decisions to publish are based entirely on editorial 
criteria and the editors and reviewers will not have access 
to the information on the author’s ability to pay the Article 
Processing Charge. Springer Nature is a partner of 
AGORA, HINARI, INASP - you can find more information 
here: http://www.nature.com/info/partners.html 
 
Open Access Funding 
Visit Springer Nature's open access funding page for 
information about research funders and institutions that 
provide funding for open access. 
 
Springer Nature also offers an APC support service to 
make it easier for Springer Nature authors to discover and 
apply for open access funding. For advice on what funding 
is available to you and help in approaching funders and 
institutions, please contact us at openaccess@nature.com. 
 
For more information about Springer Nature 's open access 
publishing options and policies, please see our open 
access homepage. 
 
 
EDITORIAL POLICIES 
 
 
Duplicate Publication 
Papers must be original and not published or submitted for 
publication elsewhere. This rule also applies to non-English 
language publications. Springer Nature allows and 
encourages prior publication on recognized community 
preprint servers for review by other scientists before formal 
submission to a journal. The details of the preprint server 
concerned and any accession numbers should be included 
in the cover letter accompanying manuscript submission. 
This policy does not extend to preprints available to the 
media or that are otherwise publicized outside the scientific 
community before or during the submission and 
consideration process. 
 
Permissions 
If a table or figure has been published before, the authors 
must obtain written permission to reproduce the material in 
both print and electronic formats from the copyright owner 
and submit it with the manuscript. This follows for quotes, 
illustrations and other materials taken from previously 
published works not in the public domain. The original 
source should be cited in the figure caption or table 
footnote. 
 
Clinical Trials 
As defined by the International Committee of Medical 
Journal Editors (ICMJE), a clinical trial is any research 
project that prospectively assigns human subjects to 
intervention and comparison groups to study the cause-and-
effect relationship between a medical intervention and a 
health outcome. A medical intervention is any intervention 
used to modify a health outcome and includes but is not 
limited to drugs, surgical procedures, devices, behavioural 
treatments, and process-of-care changes. A trial must have 
at least one prospectively assigned concurrent control or 
comparison group in order to trigger the requirement for 
registration. Nonrandomised trials are not exempt from the 
registration requirement if they meet the above criteria. 
 
When reporting experiments on human subjects, please 
indicate whether the procedures were in accordance with 
the ethical standards of the responsible committee on 
human experimentation (institutional or regional) or with the 
Helsinki Declaration of 1975 (as revised in 1983).  Include 
Institutional Review Board or Animal Care and Use 
Committee approvals. 
 
All clinical trials must be registered in a public registry prior 
to submission. The journal follows the trials registration 
policy of the ICMJE (www.icmje.org) and considers only 
trials that have been appropriately registered before 
submission, regardless of when the trial closed to 
enrolment. Acceptable registries must meet the following 
ICMJE requirements:  
 
• be publicly available, searchable, and open to all 
prospective registrants  
• have a validation mechanism for registration data  
• be managed by a not-for-profit organization  
 
The trial registry number for eligible papers will be collected 
during the submission process. 
 
Springer Nature endorses the toolkits and guidelines 
produced by the following bodies:  
 
Committee on Publication Ethics 
Good Publication Practice  
Medical Publishing Insights and Practices Initiative 
 
Authorship 
The journal recommends that authorship be based on the 
following four criteria: 
 
• Substantial contributions to the conception or design of 
the work; or the acquisition, analysis, or interpretation 
of data for the work; AND 
• Drafting the work or revising it critically for important 
intellectual content; AND 
• Final approval of the version to be published; AND 
• Agreement to be accountable for all aspects of the 
work in ensuring that questions related to the accuracy 
or integrity of any part of the work are appropriately 
investigated and resolved. 
 
All those designated as authors should meet all four criteria 
for authorship, and all who meet the four criteria should be 
identified as authors. 
 
Competing Interests 
In the interests of transparency and to help readers form 
their own judgments of potential bias, authors must declare 
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whether or not there are any competing interests in relation 
to the work described. This information must be included in 
their cover letter and after the acknowledgements of their 
manuscript. In cases where the authors declare a 
competing interest, a statement to that effect is published as 
part of the article. If no such conflict exists, the statement 
will simply read that the authors have nothing to disclose. 
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